David Machin

Active 1978–2024

Also published as
David Machín
102
Papers
24,135
Citations
83
h-index
101
i10-index

Citations

Citations per year for David Machin1940: 1 citations1983: 1 citations1984: 1 citations1985: 3 citations1986: 13 citations1987: 6 citations1988: 9 citations1989: 15 citations1990: 22 citations1991: 20 citations1992: 11 citations1993: 26 citations1994: 24 citations1995: 47 citations1996: 56 citations1997: 47 citations1998: 70 citations1999: 71 citations2000: 79 citations2001: 85 citations2002: 118 citations2003: 143 citations2004: 142 citations2005: 165 citations2006: 150 citations2007: 162 citations2008: 153 citations2009: 149 citations2010: 189 citations2011: 143 citations2012: 153 citations2013: 127 citations2014: 125 citations2015: 153 citations2016: 119 citations2017: 131 citations2018: 82 citations2019: 344 citations2020: 390 citations2021: 324 citations2022: 228 citations2023: 164 citations2024: 216 citations2025: 91 citations2026: 1 citations1941–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,490 citing papers, 19.4% of this breakdownUnited Kingdom: 887 citing papers, 11.5% of this breakdownChina: 439 citing papers, 5.7% of this breakdownGermany: 426 citing papers, 5.5% of this breakdownNetherlands: 361 citing papers, 4.7% of this breakdownItaly: 350 citing papers, 4.6% of this breakdownCanada: 347 citing papers, 4.5% of this breakdownFrance: 312 citing papers, 4.1% of this breakdownAustralia: 271 citing papers, 3.5% of this breakdownSweden: 252 citing papers, 3.3% of this breakdownSpain: 195 citing papers, 2.5% of this breakdownSingapore: 167 citing papers, 2.2% of this breakdown
0%19.4%Other 28.5%

Fields

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Engineering4.2%
  • Health Professions2.6%
  • Social Sciences2.4%
  • Economics, Econometrics and Finance1.8%
  • Other11.8%

Topics

  • Neuroblastoma Research and Treatments4.2%
  • Cancer survivorship and care2.2%
  • Cancer, Hypoxia, and Metabolism2%
  • Head and Neck Cancer Studies1.8%
  • Glioma Diagnosis and Treatment1.6%
  • Hepatocellular Carcinoma Treatment and Prognosis1.5%
  • Other86.7%

Coauthors

All papers

Open in search
  1. The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 cited by 1,899

  2. Sample Size Tables for Clinical Studies

    Authors: , , , - 2008 cited by 1,344

  3. Quality of Life: The Assessment, Analysis and Reporting of Patient-reported Outcomes

    Authors: , - 2016 cited by 321

  4. Ocular Component Growth Curves among Singaporean Children with Different Refractive Error Status

    Authors: , , , , - Investigative Ophthalmology & Visual Science 2010 cited by 170

  5. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C Kalifa, Marie‐Anne Raquin, Joris Verlooy, Volkmar Hans, Torsten Pietsch, Wolfram Scheurlen, Johannes A. Hainfellner, Felice Giangaspero, James W. Ironside, Keith Robson, Kari Skullerud, David Scheie, Nn Nn, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella‐Branger, Arielle Lellouch-Toubiana, Monika Warmuth‐Metz, Daniela Prayer, Milena Calderone, Tim Jaspan, S. J. Bakke, Eli Abraham Vázquez, D. Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, J. Giralt, C. Carrié, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zérah, Bettina Wabbels, Maria Luisa Pinello, Alistair R. Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernáiz Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Strömberg, José M. Indiano, C Rodary, Éric Bouffet, Didier Frappaz, Andreas Faldum, Angela Emser, Gian Luca De Salvo, Suzanne Stephens, David Machin, Marie‐Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto, Martin Schrappe, Richard Sposto - European Journal of Cancer 2017 cited by 152

  6. Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes

    Authors: , - 2007 cited by 1,423

  7. Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 652

  8. Sample Sizes for Clinical, Laboratory and Epidemiology Studies

    Authors: , , , - 2018 cited by 176

  9. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

    Authors: , , , , , , , , , , , - The Lancet 1997 cited by 383

  10. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

    Authors: , , , , , - The Lancet Oncology 2008 cited by 341

  11. Survival Analysis

    Authors: , , - 2006 cited by 212

  12. Quality of Life

    Authors: , - 2000 cited by 857

  13. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1996 cited by 722

  14. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

    Authors: , , , , , , , , , - Pediatric Blood & Cancer 2020 cited by 65

  15. How to Do Critical Discourse Analysis: A Multimodal Introduction

    Authors: , - 2023 cited by 1,204

  16. What is multimodal critical discourse studies?

    Authors: - Critical Discourse Studies 2013 cited by 469

  17. Early‐stage cervical carcinoma, radical hysterectomy, and sexual function

    Authors: , , , , , - Cancer 2003 cited by 362

  18. Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

    Authors: , , , , , - European Journal of Cancer 1997 cited by 162

  19. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer

    Authors: , , , , , - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 321

  20. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

    Authors: , , , , , , - Hepatology 2002 cited by 211

  21. Ocular Biometry and Refraction in Mongolian Adults

    Authors: , , , , , , , , - Investigative Ophthalmology & Visual Science 2004 cited by 198

  22. Poly-Methyl Pentene Oxygenators Have Improved Gas Exchange Capability and Reduced Transfusion Requirements in Adult Extracorporeal Membrane Oxygenation

    Authors: , , , , , , , - ASAIO Journal 2005 cited by 158

  23. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial

    Authors: , , , , , , , , , , , , , , - European Journal of Cancer 2009 cited by 150

  24. Quality of life in an urban Asian population: the impact of ethnicity and socio-economic status

    Authors: , , , , , , , , - Social Science & Medicine 2003 cited by 135